[1]
SaifM., KaleyK., BrennanM., GarconM., RodriguezG., and RodriguezT., “A Retrospective Study of Capecitabine/Temozolomide (CAPTEM) Regimen in the Treatment of Metastatic Pancreatic Neuroendocrine Tumors (pNETs) after Failing Previous Therapy”, JOP, vol. 14, no. 5, pp. 498-501, Sep. 2013.